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l rights reserved.© 2014 Elsevier Inc. All rights reserved.Sporotrichosis is a subcutaneous cosmopolitan mycosis that affects
humans and other animals, with Latin America, South Africa, India, and
Japan as the areas of high endemicity (Lopez-Romero et al., 2011). This
infection is caused by the dimorphic fungus previously described as a
single species, Sporothrix schenckii, but recently, the so-called S. schenckii
complex has been described comprising the medically relevant agents
of sporotrichosis, Sporothrix brasiliensis, Sporothrix globosa, Sporothrix
luriei, Sporothrix mexicana, and Sporothrix schenckii sensu stricto
(Marimon et al., 2007, 2008; de Meyer et al., 2008). Other species
such as Sporothrix pallidahave only been isolated from the environment
(Marimon et al., 2007, 2008; de Meyer et al., 2008; Madrid et al., 2009;
Romeo et al., 2011). An identiﬁcation key for the Sporothrix species
complex differentiation has been proposed (Marimon et al., 2007)
including analysis of conidial morphology, auxonogram analysis of
rafﬁnose and sucrose assimilation, and sequencing of calmodulin (CAL)
and/or β-tubulin (β-tub) genes (Marimon et al., 2007; Oliveira et al.,
2011; Rodrigues et al., 2013). Recently, Zhouet al. (2013) suggested that
internal transcribed spacer region analysis could also be applied for
identiﬁcation at the species level of the Sporothrix complex.
In humans, sporotrichosis is usually associated with puncture
injuries in farmers, ﬂorists, leisure gardeners, nursery workers, land-
scapers, or greenhouse workers. In 2008, a sporotrichosis epidemic
was described in Rio de Janeiro, Brazil, in which the transmission ofthe disease occurred mainly through scratches or bites of S. schenckii
sensu lato–infected cats (Schubach et al., 2008). Few cases of
sporotrichosis have been described in Europe, mainly in Italy but
also in Spain, United Kingdom, and Portugal (Cafarchia et al., 2007;
Dias et al., 2011). However, the Portuguese case of human sporo-
trichosis due to S.mexicana occurred in a patient who had traveled to
Malaysia in 2003 and, therefore, could not be regarded as autochthone
(Dias et al., 2011).
In this study, we characterize a new case of human sporotrichosis
identiﬁed in Lisbon. This case occurred in an immunocompetent
patient, which developed skin lesion in the right hand with localized
limphocutaneous sporotrichosis (Fig.1). The patient did not remem-
ber the date or the local where the trauma occurred and, to our
knowledge, has never left Portugal. Skin biopsy was received at the
INSA Mycology Laboratory for testing. Direct microscopic examina-
tion with 10% KOH and culture of biopsy fragments on enriched
medium (Blood agar) and Sabouraud agar, followed by incubation at
35 °C for 5–10days, allowed the isolation of strain INSA378027. The
infecting isolate was initially identiﬁed as S. schenckii based on mor-
phologic features. In order to conﬁrm the identity of the isolate, a
detailedphenotypic analysiswasperformed, including4 control strains:
the type strain of S. brasiliensis CBS 120339 (former IPEC16490)
(Marimon et al., 2007) and the reference strains IPEC27722
(S. schenckii), IPEC27135 (S. globosa), and MUM11.02 (S. mexicana)
(Dias et al., 2011; Oliveira et al., 2010, 2011). The microscopic features
and sporulation analyzed in Cornmeal and Potato dextrose agar (PDA)
showed clusters of intercalary or terminal conidia formed by sympodial
growth from differentiated conidiophores on both media. Sympodial
Fig. 1. Skin lesion on the right hand of patient with localized limphocutaneous
sporotrichosis.
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dominantly globose and dematiaceous (Fig. 2C and D). The colony
diameter on PDA after 21 days of incubation attained 35 mm at 30 °C
(Fig. 2B) and 5 mm at 37 °C (Fig. 2A). The conversion to the yeast form
was achieved by incubating the isolate on Brain Heart Infusion
agar slants at 35 °C ± 2 °C for 7 days in a single subculture. Carbohy-
drate assimilation tests run in triplicate showed that the Sporothrix
isolate (INSA378027) assimilated glucose as well as sucrose and did
not assimilate rafﬁnose, an atypical phenotype of S. globosa species
(Marimon et al., 2007).
Genomic DNA was extracted from the mycelial phase for se-
quencing of the partial β-tub-encoding gene (Marimon et al., 2007)
and partial CAL-encoding gene (Oliveira et al., 2010) and for T3B
PCR ﬁngerprinting (Oliveira et al., 2012). The BLAST analysis com-
paring the β-tub and CAL sequences obtained for INSA378027 iso-
late in the NCBI GenBank database identiﬁed this isolate as S. globosa
with 99–100% similarity with other S. globosa sequences (AM116961,
AM116964, AM116965, AM116966, AM116967, GU456632,
KC121567, AM116907, AM116908). Moreover, comparison and phy-
logenetic analysis of the partial β-tub and CAL sequences obtained
from S. globosa strain INSA378027 with the reference strain FMR8600
available in GenBank database presented 100% similarity among
them and also showed high bootstrap support values for both genes
(Fig. 3A and B). The /sequences obtained for β-tub- and CAL-encodingFig. 2. S. globosa: morphological aspects at 37 °C (A), and 30 °C (B). SEM pgenes were deposited in the GenBank database under accession
number KC716083 and KF437620. The T3B PCR ﬁngerprinting proﬁle
obtained for strain INSA378027 was identical to the S. globosa refe-
rence strain, corroborating once more the S. globosa identiﬁca-
tion (Fig. 3C). In vitro antifungal disk diffusion susceptibility testing
was determined (CLSI, 2010) and showed an inhibition zone diam-
eter of 50 mm to ketoconazole and 40 mm to miconazole, suggest-
ing in vitro susceptibility to these antifungals. However, the disk
inhibition zone diameter to ﬂuconazole, itraconazole, and voricona-
zole was less than 0.5 mm, indicating in vitro reduced susceptibil-
ity to these antifungals, data similar to those reported by other
study with isolates of S. globosa (Marimon et al., 2008). Overall,
our results indicate that the reported infection was due to
S. globosa and highlight the need of an integrated phenotypic
and molecular analysis for the identiﬁcation of Sporothrix isolates,
as previously suggested (Oliveira et al., 2011; Rodrigues et al.,
2013; Zhou et al., 2013).
Isolates of S. globosa have been reported from United Kingdom,
Spain, Italy, China, Japan, USA, India, Mexico, Guatemala, Brazil, and
Colombia (Madrid et al., 2009; Cafarchia et al., 2007; Dias et al., 2011;
Oliveira et al., 2010, 2011). In this study, we report the identiﬁca-
tion of the ﬁrst autochthone sporotrichosis case in Portugal due to
S. globosa and showing in vitro reduced susceptibility to ﬂuconazole,
itraconazole, and voriconazole. This report indicates that sporotri-
chosis may be underdiagnosed particularly in Southern Europe and
suggests Portugal as an emerging area for this fungal infection.Acknowledgments
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